The Use of Wearable Devices in Oncology Patients: A Systematic Review
The Oncologist · 04.04.2024 · 29 (4) · e419-e430
DOI: 10.1093/oncolo/oyad305 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Oncologist, online erschienen am 16.11.2023. Verfasst von Ronald Chow und 11 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Wearable Electronic Devices, Neoplasms. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CARO-CROF Pamela Catton Summer Studentship Award, Robert L. Tundermann and Christine E. Couturier philanthropic funds.
Abstract (Originalsprache)
Introduction
The aim of this systematic review was to summarize the current literature on wearable technologies in oncology patients for the purpose of prognostication, treatment monitoring, and rehabilitation planning.
Methods
A search was conducted in Medline ALL, Cochrane Central Register of Controlled Trials, Embase, Emcare, CINAHL, Scopus, and Web of Science, up until February 2022. Articles were included if they reported on consumer grade and/or non-commercial wearable devices in the setting of either prognostication, treatment monitoring or rehabilitation.
Results
We found 199 studies reporting on 18 513 patients suitable for inclusion. One hundred and eleven studies used wearable device data primarily for the purposes of rehabilitation, 68 for treatment monitoring, and 20 for prognostication. The most commonly-reported brands of wearable devices were ActiGraph (71 studies; 36%), Fitbit (37 studies; 19%), Garmin (13 studies; 7%), and ActivPAL (11 studies; 6%). Daily minutes of physical activity were measured in 121 studies (61%), and daily step counts were measured in 93 studies (47%). Adherence was reported in 86 studies, and ranged from 40% to 100%; of these, 63 (74%) reported adherence in excess of 80%.
Conclusion
Wearable devices may provide valuable data for the purposes of treatment monitoring, prognostication, and rehabilitation. Future studies should investigate live-time monitoring of collected data, which may facilitate directed interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- Institute of Biomedical Engineering, Faculty of Applied Sciences & Engineering, University of Toronto, Toronto, ON, Canada.
- The Hospital for Sick Children, Toronto, ON, Canada.
ORCID-Profile: Ronald Chow, James H B Im, Natasha B Leighl, Philip Wong, Srinivas Raman
Förderung
- CARO-CROF Pamela Catton Summer Studentship Award
- Robert L. Tundermann and Christine E. Couturier philanthropic funds
Zitieren
APA
Chow, R., Drkulec, H., Im, J. H. B., Tsai, J., Nafees, A., Kumar, S., Hou, T., Fazelzad, R., Leighl, N. B., Krzyzanowska, M., Wong, P., & Raman, S. (2024). The Use of Wearable Devices in Oncology Patients: A Systematic Review. The Oncologist, 29(4), e419-e430. https://doi.org/10.1093/oncolo/oyad305
Vancouver
Chow R, Drkulec H, Im JHB, Tsai J, Nafees A, Kumar S, et al. The Use of Wearable Devices in Oncology Patients: A Systematic Review. The Oncologist. 2024;29(4):e419-e430. doi:10.1093/oncolo/oyad305
BibTeX
@article{Chow2024,
author = {Chow, Ronald and Drkulec, Hannah and Im, James H B and Tsai, Jane and Nafees, Abdulwadud and Kumar, Swetlana and Hou, Tristan and Fazelzad, Rouhi and Leighl, Natasha B and Krzyzanowska, Monika and Wong, Philip and Raman, Srinivas},
title = {The Use of Wearable Devices in Oncology Patients: A Systematic Review},
journal = {The Oncologist},
year = {2024},
volume = {29},
number = {4},
pages = {e419--e430},
doi = {10.1093/oncolo/oyad305}
}
EUVIMED